Drug
HU007
HU007 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
3
75%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
3(75.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (25.0%)
Phase 33 (75.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
HU007 in Patients with Dry Eye Syndrome
NCT05743764
completedphase_3
HU007 Eye Drops in Patients With Dry Eye Syndrome
NCT04384991
completedphase_3
Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome
NCT03461575
completedphase_2
Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome
NCT02917512
Clinical Trials (4)
Showing 4 of 4 trials
NCT05743764Phase 3
HU007 in Patients with Dry Eye Syndrome
NCT04384991Phase 3
HU007 Eye Drops in Patients With Dry Eye Syndrome
NCT03461575Phase 3
Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome
NCT02917512Phase 2
Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4